| Literature DB >> 35505429 |
Jonas Ordell Frederiksen1, Catarina Malmberg2, Dennis Karimi2, Peter Toft Tengberg2, Anders Troelsen2, Mads Terndrup2.
Abstract
BACKGROUND: Recent systematic reviews support that non-operative management should be the standard treatment for all stable isolated lateral malleolar fractures (ILMFs), regardless of fibular fracture displacement. Surgical fixation of ILMFs carries a risk of adverse events (AEs), and many patients will later require implant removal. We wanted to estimate the incidence of AEs requiring revision after surgical fixation of "potentially stable" displaced ILMFs before non-operative treatment became standard care in our department.Entities:
Keywords: Adverse events; Ankle fractures; Isolated lateral malleolar fractures; Stability-based classification; Talar shift
Mesh:
Year: 2022 PMID: 35505429 PMCID: PMC9066775 DOI: 10.1186/s13018-022-03135-z
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.677
Fig. 1Radiograph with measurements. 1. Maximal fibular fracture diastasis, measured perpendicular to the fracture line, in any initial non-weightbearing, non-stress radiographic view (anterior/posterior, lateral or mortise). 2. Superior clear space (SCS), measured from the superior border of the talar dome at the highest point to the inferior border of the tibial plafond [21]. 3. Medial perpendicular clear space (MpCS), measured as the distance between the medial border of the talus and the lateral border of the medial malleolus, on a line parallel and 4 mm below the talar dome [22]
Orthopaedic surgical adverse events severity [OrthoSAVES] system
| Orthopaedic surgical adverse events severity system [ | |
|---|---|
| Grade | Definition |
| I | Adverse event does not require treatment and has no adverse effect |
| II | Adverse event requires simple or minor invasive treatment (e.g., antibiotics, Foley catheter, nasogastric [NG]) tube) and has no long-term effect on patient outcome |
| III | Adverse event requires invasive (e.g., surgery) or complex treatment (e.g., monitored bed) and is most likely to have a temporary (less than 6 months) adverse effect on outcome |
| IV | Adverse event requires invasive (e.g., surgery) or complex treatment (e.g., monitored bed) and is most likely to have a prolonged (more than 6 months) adverse effect on outcome1 |
| V | Sentinel or significant life or limb threatening event2 |
| VI | Adverse event resulting in death |
1. Any adverse event with functionally significant (i.e., patient-reported or objective) and most likely prolonged (> 6 months) adverse effect on outcome should be graded as severity grade 4, regardless of treatment complexity (or scenario where there is no possibility of treatment). 2. A sentinel event is an unexpected serious life or limb-threatening event and/or an event that necessitates institutional investigation and review to determine the root cause. For example, the wrong surgical site should automatically be graded at severity 5
Fig. 2Study population. 1. 10th revision of the International Statistical Classification of Diseases and Related Health Problems: S82.3 Fracture of lower end of tibia; S82.4 Fracture of fibula alone; S82.5 Fracture of medial malleolus; S82.6 Fracture of lateral malleolus; S82.7 Multiple fractures of lower leg; S82.8 Fractures of other parts of lower leg; S82.9 Fracture of lower leg, part unspecified. 2. Apparent TS was defined as a 2 mm increase in perpendicular medial clear space measured relative to the superior clear space in the mortise view of initial non-weightbearing, non-stress radiographs [12]
Baseline demographics and fracture classification
| Sex (% male) | 54 (50%) |
| Age in median years (range) | 45.5 [18–82] |
| 1. Normal healthy individual | 61 (56.5%) |
| 2. Mild systemic disease not limiting activity | 42 (38.9%) |
| 3. Severe systemic disease limiting activity but not incapacitating | 5 (4.6%) |
| Active Smoker (no. of patients (% of study population) | 38 (35.2%) |
| Alcohol abuse2 (no. of patients (% of study population) | 7 (6.5%) |
| Body mass index3 (mean SD [Range]) | 26.5 (± 4.3 [17.6–40.3]) |
| Diabetes Mellitus (Type I or II) (no. of patients (% of study population) | 5 (4.6%), all Type II |
| AO44B1 | 96 (88.8%) |
| AO44C1 | 10 (9.3%) |
| AO44C2 | 2 (1.9%) |
| Median fibular fracture displacement5 (millimeters) (IQR, Range) | 3,4 (1.8 [2. 1–8.9]) |
| No. of patients with 2–4 mm displacement | 76 (70.4%) |
| No. of patients with more than 4 mm displacement | 32 (29.6%) |
1. American Society of Anesthesiologists Classification (ASA Class) system for categorization of a patient’s physiological status [40]. 2. Alcohol abuse is defined as consuming more than 14 units per week for men, 7 for women [41]. 3. Body mass index defined as the body mass divided by the square of the body height, kg/m2 [42]. 4. Arbeitsgemeinshaft für Osteosyntesefragen (AO-) classification [28]. 5. Fibular fracture diastasis, as defined in Fig. 2
Internal surgical fixation technique, utilized implants and postoperative management
| Surgical fixation technique | No. of patients (% of study population) |
|---|---|
| Lateral fixation only | 95 (88%) |
| Lateral fixation + Syndesmotic fixation | 10 (9.3%) |
| Syndesmotic fixation only | 1 (0.9%) |
| Fibular Rod Fixation only | 2 (1.9%) |
| Syndesmotic fixation with 1 or 2 trans-syndesmotic screws | 11 (10.2%) |
| Intermedullary fibular nail with trans-syndesmotic screws | 2 (1.9%) |
| Orthosis (Walker boot) | 29 (26.9%) |
| Circular Cast | 67 (62%) |
| Change from circular cast to orthosis | 12 (11.1%) |
| Immediate full weightbearing | 64 (59.3%) |
| No weightbearing | 36 (33.3%) |
| Partial weightbearing | 8 (7.4%) |
| Patients restricted 2–4 weeks before full weightbearing | 18 (16.7%) |
| Patients restricted 4–6 weeks before full weightbearing | 26 (24.1%) |
| Patients restricted more than 6 weeks before full weightbearing | 4 (3.7%) |
| Duration of immobilization in a bandage (median in days [Range]) | 43 [29–95] |
| Patients immobilized in a bandage up to 50 days | 94 (88.7%) |
| Patients immobilized in a bandage more than 50 days | 12 (11.3%) |
All adverse events observed in the study population
| All adverse events1 observed in the cohort | Grade II | Grade III | Grade IV | |
|---|---|---|---|---|
| Malpositioning requiring revision | 2 (1.9%) | 0 | 0 | 2 |
| Aseptic loosening | 1 (0.9%) | 0 | 0 | 1 |
| Superficial wound | 3 (2.8%) | 3 | 0 | 0 |
| Deep wound | 3 (2.8%) | 0 | 0 | 3 |
| New onset (e.g., neuro-pathic pain,reflex dystrophy/or pain disorder) | 2 (1.9%) | 0 | 0 | 2 |
| Deep vein thrombosis | 1 (0.9%) | 0 | 1 | 0 |
| Wound dehiscence | 2 (1.9%) | 2 | 0 | 0 |
| Total | 14 (13%) | 5 | 1 | 8 |
1. Adverse events are graded and categorized with The Orthopedic Surgical Adverse Events Severity System [26]